270 related articles for article (PubMed ID: 16829212)
21. High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS.
Türkmen S; Binder A; Gerlach A; Niehage S; Theodora Melissari M; Inandiklioglu N; Dörken B; Burmeister T
Genes Chromosomes Cancer; 2014 Aug; 53(8):650-6. PubMed ID: 24729354
[TBL] [Abstract][Full Text] [Related]
22. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
[TBL] [Abstract][Full Text] [Related]
23. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
[TBL] [Abstract][Full Text] [Related]
24. AID and Igh switch region-Myc chromosomal translocations.
Unniraman S; Schatz DG
DNA Repair (Amst); 2006 Sep; 5(9-10):1259-64. PubMed ID: 16784901
[TBL] [Abstract][Full Text] [Related]
25. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
26. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
Müller JR; Janz S; Potter M
Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
[TBL] [Abstract][Full Text] [Related]
27. Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region.
Gostissa M; Yan CT; Bianco JM; Cogné M; Pinaud E; Alt FW
Nature; 2009 Dec; 462(7274):803-7. PubMed ID: 20010689
[TBL] [Abstract][Full Text] [Related]
28. Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells.
Walker BA; Wardell CP; Johnson DC; Kaiser MF; Begum DB; Dahir NB; Ross FM; Davies FE; Gonzalez D; Morgan GJ
Blood; 2013 Apr; 121(17):3413-9. PubMed ID: 23435460
[TBL] [Abstract][Full Text] [Related]
29. Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.
Tchinda J; Volpert S; Berdel WE; Büchner T; Horst J
Cancer Genet Cytogenet; 2006 Mar; 165(2):180-4. PubMed ID: 16527615
[TBL] [Abstract][Full Text] [Related]
30. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia.
Miura K; Iida S; Hanamura I; Kato M; Banno S; Ishida T; Kusumoto S; Takeuchi G; Miwa H; Nitta M; Inagaki H; Eimoto T; Nomura K; Taniwaki M; Ueda R
Cancer Sci; 2003 Apr; 94(4):350-4. PubMed ID: 12824903
[TBL] [Abstract][Full Text] [Related]
31. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
[TBL] [Abstract][Full Text] [Related]
32. In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.
Tian E; Sawyer JR; Heuck CJ; Zhang Q; van Rhee F; Barlogie B; Epstein J
Genes Chromosomes Cancer; 2014 Jul; 53(7):549-57. PubMed ID: 24638926
[TBL] [Abstract][Full Text] [Related]
33. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.
Shou Y; Martelli ML; Gabrea A; Qi Y; Brents LA; Roschke A; Dewald G; Kirsch IR; Bergsagel PL; Kuehl WM
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):228-33. PubMed ID: 10618400
[TBL] [Abstract][Full Text] [Related]
34. [The origin and formation of chromosomal translocations in multiple myeloma].
Nemec P; Kuglík P; Hájek R
Klin Onkol; 2008; 21(2):53-8. PubMed ID: 19102212
[TBL] [Abstract][Full Text] [Related]
35. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas.
Gozzetti A; Davis EM; Espinosa R; Fernald AA; Anastasi J; Le Beau MM
Cancer Res; 2002 Oct; 62(19):5523-7. PubMed ID: 12359763
[TBL] [Abstract][Full Text] [Related]
37. Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival.
Ho PJ; Brown RD; Pelka GJ; Basten A; Gibson J; Joshua DE
Blood; 2001 Jan; 97(2):490-5. PubMed ID: 11154227
[TBL] [Abstract][Full Text] [Related]
38. Deletional remodeling of c-myc-deregulating chromosomal translocations.
Kovalchuk AL; Müller JR; Janz S
Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma.
Bergsagel PL; Kuehl WM; Zhan F; Sawyer J; Barlogie B; Shaughnessy J
Blood; 2005 Jul; 106(1):296-303. PubMed ID: 15755896
[TBL] [Abstract][Full Text] [Related]
40. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.
Robbiani DF; Bothmer A; Callen E; Reina-San-Martin B; Dorsett Y; Difilippantonio S; Bolland DJ; Chen HT; Corcoran AE; Nussenzweig A; Nussenzweig MC
Cell; 2008 Dec; 135(6):1028-38. PubMed ID: 19070574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
